Marina Biotech, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 4/21/2017
Contact Info
  • 17870 Castleton Street
  • Suite 250
  • City of Industry, CA 91748

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0000737207
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1983
Employees 4 a/o Mar 31, 2017
Company Officers/Contacts
Joseph W. Ramelli CEO
Mihir Munsif COO
Larn Hwang Chief Scientific Officer
Company Directors
Vuong Trieu Chairman
Donald A Williams Independent Director, Audit Committee Member, Compensation Committee Member
Service Providers
Accounting/Auditing Firm
Squar Milner
4100 Newport Place Drive
Third Floor
Newport Beach, CA, 92660
United States
Securities Counsel
Pryor Cashman LLP OTCQX Sponsor
7 Times Square
New York, NY, 10036-6569
United States
Investor Relations Firm
Kanan Corbin Schupak & Aronow, Inc.
880 Third Avenue
6th Floor
New York, NY, 10022
United States
Company History
  • Formerly= MDRNA,Inc. until 7-2010
  • Formerly=Nastech Pharmaceutical Co., Inc. until 6-2008
MRNA Security Details
Share Structure
Market Value1 $37,895,970 a/o Jun 27, 2017
Authorized Shares 180,000,000 a/o Nov 16, 2016
Outstanding Shares 97,169,153 a/o May 15, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 49,986,393 a/o Nov 16, 2016
Par Value 0.006
Shareholders of Record 277 a/o Mar 31, 2017
Short Selling Data
Short Interest 44,976 (-80.79%)
Jun 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security